Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.595 USD | +0.23% | -3.65% | -7.00% |
17/05 | HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating | MT |
02/04 | HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.00% | 1.85Cr | |
+36.81% | 72TCr | |
+32.22% | 60TCr | |
-2.34% | 36TCr | |
+20.05% | 33TCr | |
+3.29% | 29TCr | |
+16.32% | 24TCr | |
+9.77% | 21TCr | |
-5.15% | 21TCr | |
+8.84% | 17TCr |
- Stock Market
- Equities
- KALA Stock
- News KALA BIO, Inc.
- Kala Pharmaceuticals : HC Wainwright Adjusts Kala Pharmaceuticals' Price Target to $11 From $14, Maintains Buy Rating